ArticleHealth science reports2026
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In women, breast cancer (BC) occurs more often than any other cancer worldwide and in Bangladesh. Genetic susceptibility, including functional polymorphisms affecting microRNA binding, may contribute to BC risk. This study aims to investigate the association between Methods: A hospital-based case-control study was conducted involving histopathologically confirmed 112 BC patients and 124 age-matched healthy controls (HCs). Genotyping was performed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Genotype distributions were evaluated for Hardy-Weinberg equilibrium. Associations were evaluated using logistic regression under multiple genetic models. Adjusted odds ratio (aOR) and 95% confidence intervals (CIs) were estimated with adjustment for age and BMI. Results: Genotype distributions of both rs712 and rs61764370 complied with Hardy-Weinberg Equilibrium (HWE). The rs712 TT genotype was associated with reduced BC risk (aOR = 0.065, 95% CI: 0.009-0.504; Conclusion:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.